Skip to main content

Table 2 Neurologic manifestations of HIV/AIDS in relation to outcome in 347 patients

From: The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study

Diagnosis n(%) Dead(156) n(%) Poor outcome(21) n(%) Improved(170) n(%)
cerebral toxoplasmosis 127(36.6) 56(44.1) 9(7.1) 62(48.8)
Tuberculosis meningitis 78(22.5) 42(53.8) 2(2.6) 34(43.6)
Cryptococcal meningitis 77(22.2) 37(48.1) 3(3.8) 37(48.1)
Bacterial meningitis 24(6.9) 8(33.3) 2(8.3) 14(58.3)
Tuberculoma 10(2.9) 4(40) 1(10) 5(50)
Neurosyphilis 9(2.6) 0 1(11.1) 8(88.9)
Stroke 8(2.3) 3(37.5) 0 5(62.5)
GBS 5(1.4) 1(20) 0 4(80)
Tuberculos spondylitis 5(1.4) 1(20) 2(40) 2(40)
Primary CNS lymphoma 3(0.9) 3(100) 0 0
CIDP 3(0.9) 0 0 3(100)
PML 2(0.6) 1(50) 0 1(50)
Others 3(0.9) 0 2(66.7) 1(33.3)
  1. Note: GBS Guillain-Barre syndrome, CNS central nervous system, CIDP chronic inflammatory demyelinating polyneuropathy, PML progressive multifocal leukoencephalopathy, Others = pseudotumor cerebri (n = 1), neurocycticercosis (n = 1), HIV-encephalopathy (n = 1). Stroke: ischemic (n = 6), Hemorrhagic (n = 2).